QIU Yi, ZHAO Shan-min, SHI Chang-hong, SHI Jie-ran. Immune response induced by Micrococcus luteus Rpf domain and its mutants in mice[J]. Chinese Journal of Antituberculosis, 2013, 35(5): 331-336.
[1]Derrick SC, Perera LP, Dheenadhayalan V, et al. The safety of post-exposure vaccination of mice infected with Mycobacterium tuberculosis. Vaccine, 2008, 26(48): 6092-6098.[2]吴雪琼. 新型结核病疫苗的研究现状与发展趋势.中国防痨杂志,2012,34 (3):133-137.[3]Kondratieva T, Rubakova E, Kana BD, et al. Mycobacterium tuberculosis attenuated by multiple deletions of Rpf genes effectively protects mice against TB infection. Tuberculosis(Edinb), 2011, 91(3):219-223.[4]Cohen-Gonsaud M, Keep NH, Davies AP, et al. Resuscitation-promoting factors possess a lysozyme-like domain. Trends Biochem Sci, 2004, 29(1): 7-10.[5]苏明权,岳乔红,杨柳,等. 5种结核分枝杆菌Rpf样蛋白的活性鉴定及促生长作用.中国人兽共患病学报,2008,24(9): 841-845.[6]岳晨莉,史皆然,师长宏,等. 藤黄微球菌复苏促进因子结构域及其突变体基因的克隆和表达及生物活性的测定.中华结核和呼吸杂志,2008,31(10):3761-3765.[7]Kana BD, Gordhan BG, Downing KJ, et al. The resuscitation-promoting factors of Mycobacterium tuberculosis are required for virulence and resuscitation from dormancy but are collectively dispensable for growth in vitro. Mol Microbiol, 2008, 67(3):672-684.[8]Fan A, Jian W, Shi C, et al. Production and characterization of monoclonal antibody against Mycobacterium tuberculosis RpfB domain. Hybridoma, 2010, 29(4): 327-332.[9]樊爱琳.Rpf蛋白结构域的生物学及免疫学特性的初步研究.西安:第四军医大学,2008.[10]Dietrich J.Doherty TM. Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development. APMIS, 2009,117(5-6):440-457.[11]黎友伦,罗永艾,王国治. 细胞因子及其受体在结核免疫中的作用. 国外医学内科学分册,2005,32(4): 146-167.[12]Flynn JL. Immunology of tuberculosis and implications in vaccine development. Tuberculosis(Edinb), 2004,84(1-2): 93-101.[13]Johnson BJ, Ress SR, Willcox P, et al. Clinical and immune responses of tuberculosis patients treated with low-dose IL-2 and multidrug therapy. Cytokines Mol Ther, 1995, 1(3): 185-196.[14]汤红明,刘君炎,高立芬. IFN-γ 与TNF 联合治疗结核菌感染小鼠疗效及机理的研究. 免疫学杂志,2001,17(6): 457-459.[15]要玉霞,刘传玉. 干扰素辅助治疗耐多药结核病的疗效观察. 中国防痨杂志,2003,25(1): 43-44.[16]雷建平.重新审视结核病免疫治疗研究的方向和方法.中华临床医师杂志(电子版),2010,4(7): 908-915.